Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 176370, 4 pages
http://dx.doi.org/10.1155/2011/176370
Case Report

Liver Transplantation in an Adult with Citrullinaemia Type 2

1Liver Transplant Service, Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore 169608
2Liver Transplant Service, Department of Pathology, Singapore General Hospital, Singapore 169608
3Liver Transplant Service, Department of General Surgery, Singapore General Hospital, Singapore 169608

Received 10 November 2010; Accepted 18 March 2011

Academic Editor: J. Millis

Copyright © 2011 Hui-Hui Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. E. Maestri, D. B. Clissold, and S. W. Brusilow, “Long-term survival of patients with argininosuccinate synthetase deficiency,” Journal of Pediatrics, vol. 127, no. 6, pp. 929–935, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Häberle, S. Pauli, M. Linnebank et al., “Structure of the human argininosuccinate synthetase gene and an improved system for molecular diagnostics in patients with classical and mild citrullinemia,” Human Genetics, vol. 110, no. 4, pp. 327–333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kobayashi, D. S. Sinasac, M. Iijima et al., “The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein,” Nature Genetics, vol. 22, no. 2, pp. 159–163, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Yasuda, N. Yamaguchi, K. Kobayashi et al., “Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia,” Human Genetics, vol. 107, no. 6, pp. 537–545, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Hutchin, M. A. Preece, C. Hendriksz et al., “Neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) as a cause of liver disease in infants in the UK,” Journal of Inherited Metabolic Disease, 2009. In press. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Dimmock, K. Kobayashi, M. Iijima et al., “Citrin deficiency: a novel cause of failure to thrive that responds to a high-protein, low-carbohydrate diet,” Pediatrics, vol. 119, no. 3, pp. e773–e777, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Ben-Shalom, K. Kobayashi, A. Shaag et al., “Infantile citrullinemia caused by citrin deficiency with increased dibasic amino acids,” Molecular Genetics and Metabolism, vol. 77, no. 3, pp. 202–208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tabata, J. S. Sheng, M. Ushikai et al., “Identification of 13 novel mutations including a retrotransposal insertion in SLC25A13 gene and frequency of 30 mutations found in patients with citrin deficiency,” Journal of Human Genetics, vol. 53, no. 6, pp. 534–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Fiermonte, D. Soon, A. Chaudhuri et al., “An adult with type 2 citrullinemia presenting in Europe,” New England Journal of Medicine, vol. 358, no. 13, pp. 1408–1409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Luder, A. Tabata, M. Iijima, K. Kobayashi, and H. Mandel, “Citrullinaemia type 2 outside East Asia: Israeli experience,” Journal of Inherited Metabolic Disease, vol. 29, supplement 1, p. 59, 2006. View at Google Scholar
  11. K. Kobayashi, M. Iijima, T Yasuda, S. Ikeda, and T. Saheki, “Citrin deficiency,” Journal of the Japan Pediatric Society, vol. 110, pp. 1057–1059, 2006. View at Google Scholar
  12. K. Kobayashi, M. Nakata, H. Terazono, T. Shinsato, and T. Saheki, “Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia,” FEBS Letters, vol. 372, no. 1, pp. 69–73, 1995. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kobayashi, M. Horiuchi, and T. Saheki, “Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult- onset type II citrullinemia,” Hepatology, vol. 25, no. 5, pp. 1160–1165, 1997. View at Google Scholar · View at Scopus
  14. S. I. Ikeda, S. Kawa, Y. I. Takei et al., “Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathologic findings,” Annals of Internal Medicine, vol. 141, no. 7, pp. W109–W110, 2004. View at Google Scholar · View at Scopus
  15. T. Saheki and K. Kobayashi, “Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD),” Journal of Human Genetics, vol. 47, no. 7, pp. 333–341, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Imamura, K. Kobayashi, T. Shibatou et al., “Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease,” Hepatology Research, vol. 26, no. 1, pp. 68–72, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Saheki, M. Iijima, X. L. Meng et al., “Citrin/mitochondrial glycerol-3-phosphate dehydrogenase double knock-out mice recapitulate features of human citrin deficiency,” Journal of Biological Chemistry, vol. 282, no. 34, pp. 25041–25052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Saheki, K. Kobayashi, M. Iijima et al., “Pathophysiology of citrin deficiency,” in Hepatic Encephalopathy and Nitrogen Metabolism, D. Haussinger, G. Kircheis, and F. Schliess, Eds., pp. 320–328, Springer, Berlin, Germany, 2006. View at Google Scholar
  19. B. K. Burton, “Urea cycle disorders,” Clinics in Liver Disease, vol. 4, no. 4, pp. 815–830, 2000. View at Google Scholar · View at Scopus
  20. P. F. Whitington, E. M. Alonso, J. T. Boyle et al., “Liver transplantation for the treatment of urea cycle disorders,” Journal of Inherited Metabolic Disease, vol. 21, supplement 1, pp. 112–118, 1998. View at Google Scholar
  21. K. Takenaka, I. Yasuda, H. Araki et al., “Type II citrullinemia in an elderly patient treated with living related partial liver transplantation,” Internal Medicine, vol. 39, no. 7, pp. 553–558, 2000. View at Google Scholar · View at Scopus
  22. S. Todo, T. E. Starzl, A. Tzakis et al., “Orthotopic liver transplantation for urea cycle enzyme deficiency,” Hepatology, vol. 15, no. 3, pp. 419–422, 1992. View at Google Scholar · View at Scopus
  23. M. Yazaki, S. I. Ikeda, Y. I. Takei et al., “Complete neurological recovery of an adult patient with type II citrullinemia after living related partial liver transplantation,” Transplantation, vol. 62, no. 11, pp. 1679–1681, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kawamoto, R. W. Strong, P. Kerlin et al., “Orthotopic liver transplantation for adult-onset type II citrullinaemia,” Clinical Transplantation, vol. 11, no. 5, pp. 453–458, 1997. View at Google Scholar · View at Scopus
  25. D. Morioka, M. Kasahara, Y. Takada et al., “Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide english literature and 13 cases at Kyoto University,” Liver Transplantation, vol. 11, no. 11, pp. 1332–1342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Kasahara, S. Ohwada, T. Takeichi et al., “Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor,” Transplantation, vol. 71, no. 1, pp. 157–159, 2001. View at Google Scholar · View at Scopus
  27. M. Yazaki, Y. Hashikura, Y. I. Takei et al., “Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia,” Liver Transplantation, vol. 10, no. 4, pp. 550–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kasahara, Y. Takada, H. Egawa et al., “Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience,” American Journal of Transplantation, vol. 5, no. 3, pp. 558–565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Kasahara, Y. Takada, K. Kozaki et al., “Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease,” Journal of Pediatric Surgery, vol. 39, no. 7, pp. 1138–1141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Ikeda, M. Yazaki, Y. Takei et al., “Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation,” Journal of Neurology Neurosurgery and Psychiatry, vol. 71, no. 5, pp. 663–670, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Plochl, C. K. Spiss, and E. Ploschl, “Death after transplantation of a liver from a donor with unrecognized ornithine transcarbamylase deficiency,” New England Journal of Medicine, vol. 341, no. 12, pp. 921–922, 1999. View at Publisher · View at Google Scholar · View at Scopus